Clinical application of conservative rectal surgery after neoadjuvant therapy for low locally advanced rectal cancer
Phase 1
Not yet recruiting
- Conditions
- low rectal cancer
- Registration Number
- ITMCTR1900002450
- Lead Sponsor
- The Affiliated Nanjing Hospital of Nanjing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Those aged between 30 and 80 years;
2. ERUS, MR, CT and pathological biopsy were performed before operation, and the clinical staging was consistent with low locally advanced rectal cancer.
3. Agree to accept preoperative neoadjuvant therapy plus rectal conservative surgery.
Exclusion Criteria
Family history of colorectal cancer.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie tumor response to neoadjuvant therapy in low rectal cancer patients undergoing conservative surgery?
How does conservative rectal surgery compare to radical resection in oncologic outcomes for low locally advanced rectal cancer after neoadjuvant therapy?
Which biomarkers correlate with pathological complete response in low rectal cancer patients treated with neoadjuvant chemoradiotherapy before conservative surgery?
What are the long-term adverse event profiles of sphincter-preserving approaches in low rectal cancer following neoadjuvant therapy?
Are there combination therapies with neoadjuvant chemoradiotherapy improving local control rates in low rectal cancer trials like ITMCTR1900002450?